Back to Search Start Over

Mitochondrial double-stranded RNAs as a pivotal mediator in the pathogenesis of Sjӧgren's syndrome.

Authors :
Yoon J
Lee M
Ali AA
Oh YR
Choi YS
Kim S
Lee N
Jang SG
Park S
Chung JH
Kwok SK
Hyon JY
Cha S
Lee YJ
Im SG
Kim Y
Source :
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2022 Sep 27; Vol. 30, pp. 257-269. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Publication Year :
2022

Abstract

Sjӧgren's syndrome (SS) is a systemic autoimmune disease that targets the exocrine glands, resulting in impaired saliva and tear secretion. To date, type I interferons (I-IFNs) are increasingly recognized as pivotal mediators in SS, but their endogenous drivers have not been elucidated. Here, we investigate the role of mitochondrial double-stranded RNAs (mt-dsRNAs) in regulating I-IFNs and other glandular phenotypes of SS. We find that mt-dsRNAs are elevated in the saliva and tears of SS patients (n = 73 for saliva and n = 16 for tears) and in salivary glands of non-obese diabetic mice with salivary dysfunction. Using the in-house-developed 3D culture of immortalized human salivary gland cells, we show that stimulation by exogenous dsRNAs increase mt-dsRNAs, activate the innate immune system, trigger I-IFNs, and promote glandular phenotypes. These responses are mediated via the Janus kinase 1 (JAK1)/signal transducer and activator of transcription (STAT) pathway. Indeed, a small chemical inhibitor of JAK1 attenuates mtRNA elevation and immune activation. We further show that muscarinic receptor ligand acetylcholine ameliorates autoimmune characteristics by preventing mt-dsRNA-mediated immune activation. Last, direct suppression of mt-dsRNAs reverses the glandular phenotypes of SS. Altogether, our study underscores the significance of mt-dsRNA upregulation in the pathogenesis of SS and suggests mt-dsRNAs as propagators of a pseudo-viral signal in the SS target tissue.<br />Competing Interests: S.G.I. is a co-inventor of the polymeric thin-film-based 3D culture used in this study and is currently filing a patent for it. The authors declare no competing interests.<br /> (© 2022 The Author(s).)

Details

Language :
English
ISSN :
2162-2531
Volume :
30
Database :
MEDLINE
Journal :
Molecular therapy. Nucleic acids
Publication Type :
Academic Journal
Accession number :
36284513
Full Text :
https://doi.org/10.1016/j.omtn.2022.09.020